Iron deficiency without anemia causes fatigue and neuropsychological symptoms.

Iron deficiency without anemia (IDWA)—defined by low serum ferritin despite normal hemoglobin levels—is increasingly recognized as a clinical state capable of producing significant physical and neuropsychological symptoms. While traditional diagnostics often focus on anemia, research indicates that cellular iron depletion occurs well before hemoglobin levels drop, impacting metabolic and neurological processes.

Clinical and effectiveness evidence

Recent clinical evidence confirms that iron deficiency significantly impacts quality of life even in the absence of anemia.

• Fatigue reduction: Meta-analyses of randomized controlled trials (RCTs) involving non-anemic women (a demographic highly relevant to those in their 40s) demonstrate that iron supplementation consistently reduces subjective fatigue scores. One landmark study showed a 48% reduction in fatigue scores in non-anemic women with ferritin levels below 50 µg/L after receiving intravenous iron.
• Cognitive performance: Studies in young and middle-aged women have shown that iron status correlates with cognitive performance. Research indicates that non-anemic women with low ferritin (typically <12–20 µg/L) perform more poorly on tasks involving attention, memory, and executive function compared to those with sufficient iron stores.
• Mood and sleep: Observational data link IDWA to increased risks of depression and anxiety. In blood donors and women of reproductive age, low ferritin levels are associated with higher psychological distress scores. While direct RCTs on sleep disturbances are more limited, the stabilization of iron levels is clinically observed to improve overall sleep quality alongside mood improvements.

Mechanistic explanations

The symptoms of IDWA are driven by iron’s role as an essential cofactor in cellular and neurological functions.

• Mitochondrial dysfunction: Iron is critical for the mitochondrial respiratory chain, specifically as a component of cytochromes and iron-sulfur cluster enzymes. In IDWA, mitochondrial complex I activity can be impaired, leading to less efficient ATP (energy) production in muscle and nerve cells, which manifests as physical and mental fatigue.
• Neurotransmitter synthesis: Iron is the rate-limiting cofactor for tyrosine hydroxylase and tryptophan hydroxylase, the enzymes required to synthesize dopamine, norepinephrine, and serotonin. Low iron availability in the brain disrupts these monoamine pathways, directly contributing to low mood and cognitive "fog."
• Sleep architecture: Iron is necessary for the proper function of the dopaminergic system, which regulates the sleep-wake cycle. Iron deficiency is a known primary driver of Restless Legs Syndrome (RLS) and periodic limb movement disorder, both of which cause significant sleep fragmentation even without full-blown anemia.

Bottom line

Iron deficiency without anemia is a scientifically supported cause of fatigue, impaired cognition, and mood disturbances. For women in their 40s, maintaining ferritin levels above 30–50 µg/L is often necessary to prevent these symptoms, as cellular iron needs frequently exceed what is required for basic hemoglobin production.